Company Filing History:
3 out of 669 
1 out of 147 
Years Active: 2013-2016
Title: Adam Shilling: Innovator in Pharmaceutical Chemistry
Introduction
Adam Shilling is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 3 patents. His work focuses on the development of innovative chemical compounds that have potential therapeutic applications.
Latest Patents
Among his latest patents are the hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile. This invention provides valuable derivatives that could enhance the efficacy of treatments in various medical conditions. The detailed description of these compounds highlights their potential in advancing pharmaceutical research.
Career Highlights
Adam has worked with prominent companies in the pharmaceutical industry, including Incyte Corporation and Incyte Holdings Corporation. His experience in these organizations has allowed him to collaborate with leading experts and contribute to groundbreaking research in drug development.
Collaborations
Throughout his career, Adam has collaborated with talented individuals such as James David Rodgers and Argyrios George Arvanitis. These partnerships have fostered innovation and have been instrumental in the advancement of his research projects.
Conclusion
Adam Shilling is a distinguished inventor whose work in pharmaceutical chemistry continues to impact the industry. His innovative patents and collaborations reflect his commitment to advancing medical science.